Main Goal

WELCOME is an ambitious project aimingto create a technology solution enabling step-change in the integrated care of, and self-management by, patients suffering from Chronic Obstructive Pulmonary Disease (COPD) with comorbidities Chronic Heart Failure, Diabetes, Anxiety and Depression.


The main goal is to develop, test, validate and commercialise a fully integrated proactive and personalised technology solution, providing 360° data from clinician, patient and external inputs. The technology solution combines a smart vest including sensors which measure and monitor specific COPD patient indicators. Combined with other personalised patient and environmental information, real-time data can be automatically uploaded to highly secure cloud-based patient medical records. From this hub, patients, clinicians and community health professionals can better monitor and manage integrated personalised care plans.



The WELCOME solution for the patient will be based on:

  • An adjustable, wearable and washable vest providing continuous monitoring of a large number of sensors each one measuring various physiological signals, like chest sounds, pleural effusion, tachycardia or arrhythmia, atrial fibrillation etc,. The vest will be comfortable, inconspicuous, and easy to put on by the patient, it willrequire simple maintenance (simultaneous sensor recharging, normal washing procedure) and can be modified according to each patient’s individual needs.
  • Wearable sensors for measuring blood trends like glucose, cholesterols, triglycerides, potassium, serum creatinine, blood pressure etc in a periodic basis.
  • Inhaler devices for measuring and evaluating the medical adherence of the patients.

Remote, continuous monitoring and analysis of patient multi-parametric data, such as physiological, environmental, emotional and genetic data, will be used for designing the personalized integrated care applications ranging from self-care guidance and regulation (e.g e-coaching) at home and outdoors to professional primary and secondary health-care support (e.g including telemonitoring and remote support or comprehensive expert support at the clinic). The process will be facilitated by a cloud based Decision Support System, providing tatistical/intelligent analysis of the therapy policies and patient conditions enhanced by multiple patients’ data fusion and discovery of patterns on the patient’s disease progress.


Great attention will be paid to the small-scale validation of the project and its impact on healthcare in five countries (Greece, UK, Ireland, Germany and Nethelands).


WELCOME High Level View (1)



Royal College of Surgeons In Ireland

Universitätsklinikum Schleswig-Holstein

Universidade de Coimbra

Inventya Ltd

Smartex S.R.L.

CSEM Centre Suisse d’Électronique et de Microtechnique SA

Croydon Healthcare NHS Trust

Ciro+ B.V.

Kristronics GmbH

Aristotle University of Thessaloniki


Kingston University Higher Education Corporation

Christian-Albrechts-Universität zu Kiel
More tweets
Reuters_Health Reuters Health@Reuters_Health
Roche lauds new flu drug trial as Tamiflu suffers generics hit https://t.co/vuPJzAUxIt
peterohnemus Peter Ohnemus@peterohnemus
RT @MattParkDacadoo: Healthcare costs are exploding! Modifiable risk factors (exercise, nutrition, smoking, drinking, stress) are big driv…
peterohnemus Peter Ohnemus@peterohnemus
RT @dacadoo: #Summer is well and truly here, and as the temperatures rise it's tempting to get #outside and enjoy the good weather. As #run…
peterohnemus Peter Ohnemus@peterohnemus
RT @HeuerM: We're living in one of the best eras for #mentalhealth on the whole. Humanity has never understood as much as we do now, and pe…
Back to top